Top Ranked Momentum Stocks to Buy for February 26th

A DLHC

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, February 26th:

Agilent Technologies, Inc. (A - Free Report) : This provider of application focused solutions to the life sciences, diagnostics and applied chemicals industries has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.

Agilent Technologies, Inc. Price and Consensus

Agilent Technologies' shares gained 7.9% over the last one month more than S&P 500’s gain of 5.5%. The company possesses a Momentum Score of A.

Agilent Technologies, Inc. Price

Atlas Air Worldwide Holdings, Inc. : This provider of outsourced aircraft and aviation operating services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.8% over the last 60 days.

Atlas Air Worldwide Holdings Price and Consensus

Atlas Air Worldwide’s shares gained 7.9% over the last one month. The company possesses a Momentum Score of B.

Atlas Air Worldwide Holdings Price

DLH Holdings Corp. (DLHC - Free Report) : This healthcare and social services provider has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.3% over the last 60 days.

DLH Holdings Corp. Price and Consensus

DLH Holdings’ shares gained 20.5% over the last one month. The company possesses a Momentum Score of A.

DLH Holdings Corp. Price

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>